Bupropion versus Methylphenidate in the Treatment of Attention-Deficit Hyperactivity Disorder
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Objective In the treatment of attention-deficit hyperactivity disorder (ADHD), the efficacy of the tricyclic antidepressants and monoamine oxidase inhibitor antidepressants has been compared with that of both placebo and the stimulants (methylphenidate and/or dextroamphetamine). However, the effectiveness of bupropion has been contrasted only with placebo. The primary aim of this study was to contrast the efficacy of bupropion with that of methylphenidate in the treatment of ADHD.Method A double-blind, crossover design was used in this study. After a 14-day medication washout period, 15 ADHD subjects (7 to 17 years old) were randomized to either methylphenidate or bupropion for 6 weeks, washed out for an additional 2 weeks, and then "crossed over" to the other drug. Methylphenidate was titrated to the maximum effective dose of 0.4 to 1.3 mg/kg per day (mean 0.7 mg/kg per day) and bupropion was titrated to an effective dose ranging from 1.4 to 5.7 mg/kg per day (mean 3.3 mg/kg per day).Results Both methylphenidate and bupropion produced significantly greater (p < .001) and equivalent improvement on the Iowa-Conners Teacher's Rating Scale according to both the subjects' parents and teachers. The same pattern of improvement was also noted for improvement on the Clinical Global Impression Scale, Kagan's Matching Familiar Figures Test, Continuous Performance Test, Children's Depression Inventory, Children's Manifest Anxiety Scale, and Rey Auditory-Verbal Learning Test.Conclusions In this double-blind, crossover trial, bupropion and methylphenidate were both effective and did not differ in their overall efficacy as treatments for ADHD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This includes potentially addressing CDS-related deficits in signal detection by reducing errors of omission [2, 10, 14, 39, 44, 71]”
Citations
Cites
Children’s Depression Inventory
Kovács, M. (1978) · PsycTESTS Dataset · doi:10.1037/t00788-000 · Cited by 1,151
REFLECTION-IMPULSIVITY AND READING ABILITY IN PRIMARY GRADE CHILDREN
Kagan, J. (1965) · Child Development · doi:10.1111/j.1467-8624.1965.tb05323.x · Cited by 427
HUNT, R. D., MINDERAA, R. B., & COHEN, D. J. (1985) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60065-0 · Cited by 313
A Double-Blind Placebo Controlled Study of Desipramine in the Treatment of ADD: I. Efficacy
BIEDERMAN, J., BALDESSARINI, R. J., WRIGHT, V., KNEE, D., & HARMATZ, J. S. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198909000-00022 · Cited by 310
Pelham, W. E., Greenslade, K. E., Vodde-Hamilton, M., Murphy, D. A., Greenstein, J. J., Gnagy, E. M., Guthrie, K. J., Hoover, M. D., & Dahl, R. E. (1990) · Pediatrics · doi:10.1542/peds.86.2.226 · Cited by 249
Imipramine and Methylphenidate Treatments of Hyperactive Boys: A Double-Blind Comparison
Rapoport, J. L. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760120049008 · Cited by 243
Seizures and bupropion: a review.
Davidson, J. R. T. (1989) · PubMed · Cited by 234
Treatment of bulimia with bupropion: a multicenter controlled trial.
Horne, R. L., Ferguson, J. M., Pope, H. G., Hudson, J. I., Lineberry, C. G., Ascher, J. A., & Cato, A. E. (1988) · PubMed · Cited by 212
Cardiovascular effects of bupropion in depressed patients with heart disease
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.4.512 · Cited by 167
A 102-center prospective study of seizure in association with bupropion.
Johnston, J. A., Lineberry, C. G., Ascher, J. A., Davidson, J. R. T., Khayrallah, M. A., Feighner, J. P., & Stark, P. (1991) · PubMed · Cited by 151
Research works printed but not linked: 1
- Sudden death in children treated with a tricyclic antidepressant, 1990, Med Lett, 32, 53
Cited by
Is ADHD a disinhibitory disorder?
Nigg, J. T. (2001) · Psychological Bulletin · doi:10.1037/0033-2909.127.5.571 · Cited by 878
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Dulcan, M. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199710001-00007 · Cited by 628
Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., Arnsten, A. F. T., Cohen, D. J., & Leckman, J. F. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1067 · Cited by 588
Ten-Year Review of Rating Scales. V: Scales Assessing Attention-Deficit/Hyperactivity Disorder
COLLETT, B. R., OHAN, J. L., & MYERS, K. M. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000070245.24125.b6 · Cited by 514
Metadata
- Authors
- BARRICKMAN, L. L., PERRY, P. J., ALLEN, A. J., KUPERMAN, S., ARNDT, S. V., HERRMANN, K. J., & SCHUMACHER, E.
- Affiliations
- University of Iowa (US)
- Corresponding author
- PERRY, PAUL J.
- ORCID
- ARNDT, STEPHAN V.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 1995-05
- Volume
- 34
- Issue
- 5
- Pages
- 649-657
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W2049710132
- Cited by
- 254
- References
- 39
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 5 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 7 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 3 · 2012: 7
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
- Keywords
- attention deficit hyperactivity disorder, bupropion, methylphenidate, tricyclic antidepressants, monoamine oxidase inhibitors, treatment efficacy, children and adolescents
- MeSH terms
- Adolescent, Attention Deficit Disorder with Hyperactivity, Child, Dose-Response Relationship, Drug, Double-Blind Method, Humans, Methylphenidate, Placebos, Bupropion, Treatment Outcome, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bupropion versus Methylphenidate in the Treatment of Attention-Deficit Hyperactivity Disorder. https://app.cochat.ai/papers/10.1097/00004583-199505000-00017
- The paper
- BARRICKMAN, L. L., PERRY, P. J., ALLEN, A. J., KUPERMAN, S., ARNDT, S. V., HERRMANN, K. J., & SCHUMACHER, E. (1995). Bupropion versus Methylphenidate in the Treatment of Attention-Deficit Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1097/00004583-199505000-00017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.